Plasma protein binding of frusemide in liver disease: effect of hypoalbuminaemia and hyperbilirubinaemia

Br J Clin Pharmacol. 1989 Aug;28(2):175-8. doi: 10.1111/j.1365-2125.1989.tb05412.x.

Abstract

The binding of frusemide was studied in the plasma of 20 healthy subjects and 45 patients with liver disease. The unbound percentage (mean +/- s.d.) of frusemide was 1.64 +/- 0.21 healthy subjects) and 2.24 +/- 0.79 (patients) (P less than 0.01). By grouping the patients on the basis of plasma albuminaemia and bilirubinaemia four clusters namely: 'normal concentrations of albumin and bilirubin' (A), 'hyperbilirubinaemia and normal albumin concentration' (B), 'hypoalbuminaemia and normal bilirubin concentration' (C) and 'hypoalbuminaemia and hyperbilirubinaemia' (D) were defined. The unbound percentage of frusemide was 1.80 +/- 0.36 in (A); 2.44 +/- 1.05 in (B); 2.23 +/- 0.38 in (C); 2.76 +/- 0.77 in (D). The figure for healthy volunteers was not different from A, whereas it was significantly lower than those for B and D (P less than 0.01) and for C (P less than 0.05). A lowered binding of frusemide was associated with hypoalbuminaemia or hyperbilirubinaemia.

MeSH terms

  • Adult
  • Aged
  • Blood Proteins / metabolism
  • Dialysis
  • Female
  • Furosemide / blood*
  • Humans
  • Hyperbilirubinemia / blood*
  • Liver Diseases / metabolism*
  • Male
  • Middle Aged
  • Protein Binding
  • Serum Albumin / deficiency*

Substances

  • Blood Proteins
  • Serum Albumin
  • Furosemide